STAAR Surgical Announces Participation in Upcoming Investor Conferences
May 22 2025 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), the global leader in
phakic IOLs with the EVO family of Implantable Collamer® Lenses
(EVO ICL™) for vision correction, today announced that management
will participate in the following upcoming conferences:
Stifel 2025 Virtual Ophthalmology Forum Date: Tuesday,
May 27, 2025 Format: Meetings and Webcast Fireside Chat Webcast:
2:00 PM ET, Webcast Link
Wells Fargo 2025 West Coast Bus Tour Date:
Thursday, May 29, 2025 Location: Laguna Beach, CA Format: Fireside
Chat; No Webcast
William Blair 45th Annual Growth Stock Conference Date:
Wednesday, June 4, 2025 Location: Chicago, IL Format: Meetings and
Webcast Slide Presentation Webcast: 9:40 AM ET, Webcast Link
Jefferies Global Healthcare Conference Date: Thursday,
June 5, 2025 Location: New York, NY Format: Meetings Only
Investor meeting participation is by invitation only from each
sponsoring brokerage firm. The live and archived webcast for each
event, where applicable, will also be available on STAAR’s investor
website at https://investors.staar.com.
About STAAR Surgical
STAAR Surgical (NASDAQ: STAA) is the global leader in
implantable phakic intraocular lenses, a vision correction solution
that reduces or eliminates the need for glasses or contact lenses.
Since 1982, STAAR has been dedicated solely to ophthalmic surgery,
and for 30 years, STAAR has been designing, developing,
manufacturing, and marketing advanced Implantable Collamer® Lenses
(ICLs), using its proprietary biocompatible Collamer material.
STAAR ICL’s are clinically-proven to deliver safe long-term vision
correction without removing corneal tissue or the eye’s natural
crystalline lens. Its EVO ICL™ product line provides visual freedom
through a quick, minimally invasive procedure. STAAR has sold more
than 3 million ICLs in over 75 countries. Headquartered in Lake
Forest, California, the company operates research, development,
manufacturing, and packaging facilities in California and
Switzerland. For more information about ICL, visit www.EVOICL.com.
To learn more about STAAR, visit www.staar.com.
We intend to use our website as a means of disclosing material
non-public information about the Company and for complying with our
disclosure obligations under Regulation FD. Such disclosures will
be included on our website in the ‘Investor Relations’ sections at
investors.staar.com. Accordingly, investors should monitor such
portion of our website, in addition to following our press
releases, SEC filings and public conference calls and webcasts. In
addition, you may automatically receive email alerts and other
information about the Company when you enroll your email address by
visiting the Email Alerts section at investors.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250522329346/en/
Investors & Media Brian Moore Vice President,
Investor Relations and Corporate Development (626) 303-7902, Ext.
3023 bmoore@staar.com
Investors - Asia Niko Liu, CFA Director, Investor
Relations and Corporate Development - Asia +852-6092-5076
nliu@staar.com
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jun 2025 to Jul 2025
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jul 2024 to Jul 2025